TOT BIOPHARM International Company Limited (HKG:1875)
Hong Kong · Delayed Price · Currency is HKD 1.900
0.00 (0.00%)
Jul 16, 2025, 3:50 PM HKT
HKG:1875 Revenue
In the year 2024, TOT BIOPHARM International Company had annual revenue of 1.10B CNY with 40.70% growth. TOT BIOPHARM International Company had revenue of 577.73M in the half year ending December 31, 2024, with 122.07% growth.
Revenue
1.10B CNY
Revenue Growth
+40.70%
P/S Ratio
1.26
Revenue / Employee
1.80M CNY
Employees
611
Market Cap
1.47B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| Sino Biopharmaceutical | 30.72B |
| WuXi Biologics | 19.87B |
| Akeso | 2.26B |
| CSPC Pharmaceutical Group | 28.99B |